AYTU BIOPHARMA, INC Annual Weighted Average Number of Shares Outstanding, Diluted from 2021 to 2023

Taxonomy & unit
us-gaap: shares
Description
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
Summary
Aytu Biopharma, Inc quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from 2021 to 2023.
  • Aytu Biopharma, Inc Weighted Average Number of Shares Outstanding, Diluted for the quarter ending September 30, 2024 was 9.1M shares, a 66% increase year-over-year.
  • Aytu Biopharma, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 3.34M shares, a 127% increase from 2022.
  • Aytu Biopharma, Inc annual Weighted Average Number of Shares Outstanding, Diluted for 2022 was 1.47M shares, a 91.2% decline from 2021.
Weighted Average Number of Shares Outstanding, Diluted, Annual (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 3.34M +1.87M +127% Jul 1, 2022 Jun 30, 2023 10-K 2023-10-12
2022 1.47M -15.3M -91.2% Jul 1, 2021 Jun 30, 2022 10-K 2023-10-12
2021 16.7M Jul 1, 2020 Jun 30, 2021 10-K 2022-09-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.